Share
Market Research Report
Medical Devices

U.S. UTERINE FIBROID TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

U.S. Uterine Fibroid Treatment Market, By Procedure Type (Endometrial Ablation, MRI Guided Procedures (MRI-guided Percutaneous Laser Ablation, and MRI-guided Transcutaneous Focused Ultrasound), Hysterectomy (Abdominal Hysterectomy, Vaginal Hysterectomy, Laparoscopic Hysterectomy, Robotic Hysterectomy, and Hysteroscopic Morcellation), Myomectomy (Open Myomectomy, Laparoscopic Myomectomy, and Robotic Myomectomy), Uterine Artery Embolization, Radiofrequency Ablation, and Others) and By End User (Hospitals and Ambulatory Surgical Centers)-

  • Published In27 Apr 2026
  • Report CodeCMI3866
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Procedure Type
      • Market Snippet, By End User
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Recent Product Launches
    • Epidemiology
    • Merger, Acquisition, and Collaborations
    • Regulatory Scenario
    • Key Developments
    • PEST Analysis
  4. U.S. Uterine Fibroids Treatment Market, By Procedure Type, 2021 - 2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033(%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Endometrial Ablation
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
    • MRI Guided Procedures
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
        • MRI-guided Percutaneous Laser Ablation
        • MRI-guided Transcutaneous Focused Ultrasound
    • Hysterectomy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
        • Abdominal Hysterectomy
        • Vaginal Hysterectomy
        • Laparoscopic Hysterectomy
        • Robotic Hysterectomy
        • Hysteroscopic Morcellation
    • Myomectomy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
        • Open Myomectomy
        • Laparoscopic Myomectomy
        • Robotic Myomectomy
    • Uterine Artery Embolization
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
      • Segment Trends
    • Radiofrequency Ablation
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
      • Segment Trends
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
      • Segment Trends
  5. U.S. Uterine Fibroids Treatment Market, By End User, 2021 - 2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033(%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
  6. Competitive Landscape

    • Company Profiles
      • Blue Endo
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Boston Scientific Corporation or its affiliates
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • CooperSurgical, Inc.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Karl Storz SE & Co. KG
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Myovant Sciences GmbH (Sumitovant Biopharma Ltd.)
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Halt Medical, Inc. (Hologic, Inc.)
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • LiNA Medical ApS
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    •  Merit Medical Systems
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Olympus Corporation
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Richard Wolf GmbH
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
  7. Section

    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 30 market data tables and 22 figures on “U.S. Uterine Fibroids Treatment Market – U.S. forecast to 2033